EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP

Ping Fang, Zhengqin Ye, Ran Li iD, Dunmin She, Guannan Zong, Liya Zhang, Ying Xue iD, Keqin Zhang

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s400249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Ping Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Cardiomyopathies, MicroRNAs, Membrane Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic CardiomyopathiesMicroRNAsMembrane ProteinsGlucagon-Like Peptide-1 Receptor AgonistsAnimalsMiceMyocytes, CardiacProteomics

Stichwörter der Autor:innen

diabetic cardiomyopathyglucagon-like peptide-1 receptor agonistmicroRNA-29b-3pproteomicssarcolemmal membrane-associated protein

Substanzen

MicroRNAsMIRN29 microRNA, mouseSlmap protein, mouseMembrane ProteinsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.
  • Department of Endocrinology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, 225001, People's Republic of China.

ORCID-Profile: Ran Li, Ying Xue

Zitieren

APA

Fang, P., Ye, Z., Li, R., She, D., Zong, G., Zhang, L., Xue, Y., & Zhang, K. (2023). Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s400249

Vancouver

Fang P, Ye Z, Li R, She D, Zong G, Zhang L, et al. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s400249

BibTeX
@article{Fang2023,
  author = {Fang, Ping and Ye, Zhengqin and Li, Ran and She, Dunmin and Zong, Guannan and Zhang, Liya and Xue, Ying and Zhang, Keqin},
  title = {Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s400249}
}
Kostenlos starten →